Results 131 to 140 of about 338,947 (383)

Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial. [PDF]

, 2016
BackgroundThe development of probiotics as therapies to cure or prevent disease lags far behind that of other investigational medications. Rigorously designed phase I clinical trials are nearly non-existent in the field of probiotic research, which is a ...
Armstrong, April W, Awasthi, Smita, Freeman, Samara L, German, J Bruce, Kim, Kyoungmi, Lebrilla, Carlito B, Maverakis, Emanual, Mills, David A, Patel, Forum, Smilowitz, Jennifer T, Wilken, Reason   +10 more
core   +1 more source

Association of Tralokinumab and Adalimumab: Good Tolerance and Efficacy in a Case of Severe Atopic Dermatitis and Juvenile Idiopathic Arthritis

JEADV Clinical Practice, EarlyView.
ABSTRACT Atopic dermatitis is a chronic inflammatory and pruritic skin disease. The combination of tralokinumab with adalimumab in the treatment of inflammatory diseases had not yet been documented. It appears promising for treating severe atopic dermatitis in patients with juvenile idiopathic arthritis, offering significant improvement in skin ...
F. Rakotonandrasana, E. Puzenat, A. Ducournau, D. Popescu   +3 more
wiley   +1 more source

Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). [PDF]

, 2014
This report provides a summary of the third meeting of the Harmonising Outcome Measures for Eczema (HOME) initiative held in San Diego, CA, U.S.A., 6-7 April 2013 (HOME III).
Admani, S, Aoki, V, Apfelbacher, C, Ardeleanu, M, Barbarot, S, Berger, T, Bergman, JN, Block, J, Borok, N, Burton, T, Chalmers, JR, Chamlin, SL, Deckert, S, DeKlotz, CC, Dohil, M, Eichenfield, LF, Graff, LB, Hanifin, JM, Hebert, AA, Humphreys, R, Katoh, N, Kisa, RM, Margolis, DJ, Merhand, S, Minnillo, R, Mizutani, H, Nankervis, H, Ohya, Y, Rodgers, P, Schmitt, J, Schram, ME, Simpson, EL, Singh, J, Spuls, P, Stalder, JF, Svensson, A, Takaoka, R, Teper, A, Thomas, KS, Tom, WL, von Kobyletzki, L, Weisshaar, E, Williams, HC, Zelt, S   +43 more
core   +1 more source

Atopic Dermatitis in Childhood and Biomarkers of Male Reproductive Health: A Danish National Birth Cohort Study

JEADV Clinical Practice, EarlyView.
This study found no indication of an adverse effect of childhood atopic dermatitis on biomarkers of male reproductive health. On the contrary, we observed some indications of slightly higher sperm concentration and lower follicle‐stimulating hormone (FSH) and luteinizing hormone (LH).
Camilla Lomholt Kjersgaard, Anne Gaml‐Sørensen, Linn Håkonsen Arendt, Sandra Søgaard Tøttenborg, Karin Sørig Hougaard, Gunnar Toft, Onyebuchi A. Arah, Jens Peter Bonde, Mette Deleuran, Cecilia Høst Ramlau‐Hansen   +9 more
wiley   +1 more source

Prevalence and risk factors for atopic disease in a population of preschool children in Rome: Challenges to early intervention [PDF]

, 2016
Background: Allergic diseases are complex identities determined by an interplay of genetic and environmental factors, resulting in the clinical manifestation of the disease.
DE CASTRO, Giovanna, DE VITTORI, Valentina, Duse, Marzia, Forastiere, F, Indinnimeo, Luciana, Melengu, T, Porta, D, Tancredi, Giancarlo, Zicari, Anna Maria   +8 more
core   +1 more source

Successful Treatment of Dupilumab in Two Cases of Refractory Kimura's Disease

JEADV Clinical Practice, EarlyView.
ABSTRACT Kimura disease (KD) is a chronic inflammatory disorder characterized by subcutaneous nodules, cervical lymphadenopathy, hypereosinophilia, and elevated IgE levels. Treatment options are limited. We report two cases of refractory KD successfully treated with dupilumab.
Manon Blaise, Antoine Bertolotti, Yoann Di Filippo, Nathalie Cardot‐Leccia, Valentine Marchal, Henri Montaudié, Thierry Passeron   +6 more
wiley   +1 more source

ACTIVATED ZINC PYRITHIONE APPLICATION FOR THE ATOPIC DERMATITIS AMONG CHILDREN: MECHANISM OF ACTION, CLINICAL EFFICIENCY

Педиатрическая фармакология, 2009
Atopic dermatitis is characterized by the chronic recurrent course and often complicated by the consecutive infection and requires an adequate and regular external treatment. This article is devoted to the overview of the key pharmacodynamic and clinical
F.I. Petrovsky, D.S. Korostovtsev
doaj   +2 more sources

Successful Treatment of Erythroderma in a Psoriasis Patient, Developed After Anti‐IL‐17, Anti‐IL‐23 and Anti‐IL‐4/IL‐13 Treatment, With Deucravacitinib

JEADV Clinical Practice, EarlyView.
ABSTRACT We present the case of a 79‐year‐old female patient diagnosed with psoriasis who developed paradoxical drug reactions after administration of anti‐IL17 and anti‐IL‐23 inhibitors. Having shifted towards a rather eczematous phenotype, the patient received an anti‐IL‐4/IL‐3 inhibitor, subsequently developing erythroderma.
Tugce Guel, Luka de Vos‐Hillebrand, Dagmar Wilsmann‐Theis, Natalija Novak, Joerg Wenzel   +4 more
wiley   +1 more source

The burden of atopic dermatitis in Portuguese patients: an observational study

Scientific Reports
Atopic dermatitis (AD) is a common inflammatory skin condition that significantly affects patients' lives and imposes both economic and non-economic burdens. The precise societal and individual consequences of AD remain incompletely understood.
Pedro S. Coelho, Miguel Apalhão, Guilherme Victorino, Cristina Cardoso, Joana Camilo, João Maia Silva   +5 more
doaj   +1 more source

The Impact of Atopic Dermatitis on Sexual Function and Reproductive Desires in Women

Acta Dermato-Venereologica
Atopic dermatitis is a prevalent skin condition that affects up to 17% of adult population. It can lead to itching, pain, and other symptoms such as sleep disturbance, anxiety, and depression.
Juan-Angel Rodríguez-Pozo, Trinidad Montero-Vílchez, Pablo Diaz Calvillo, Raquel Sanabria de la Torre, Clara Ureña Paniego, Arena Ramirez-Muñoz, Salvador Arias Santiago   +6 more
doaj   +1 more source